carbamylhydrazine has been researched along with Diabetes Mellitus, Type 1 in 1 studies
carbamylhydrazine: RN given refers to parent cpd
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boomsma, F | 1 |
| van den Meiracker, AH | 1 |
| Winkel, S | 1 |
| Aanstoot, HJ | 1 |
| Batstra, MR | 1 |
| Man in 't Veld, AJ | 1 |
| Bruining, GJ | 1 |
1 other study available for carbamylhydrazine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Circulating semicarbazide-sensitive amine oxidase is raised both in type I (insulin-dependent), in type II (non-insulin-dependent) diabetes mellitus and even in childhood type I diabetes at first clinical diagnosis.
Topics: Adolescent; Adult; Aged; Amine Oxidase (Copper-Containing); Child; Child, Preschool; Diabetes Mellit | 1999 |